Literature DB >> 17505814

[Functional imaging for brain tumors (perfusion, DTI and MR spectroscopy)].

M Essig1, F Giesel, B Stieltjes, M A Weber.   

Abstract

This contribution considers the possibilities involved with using functional methods in magnetic resonance imaging (MRI) diagnostics for brain tumors. Of the functional methods available, we discuss perfusion MRI (PWI), diffusion MRI (DWI and DTI) and MR spectroscopy (H-MRS). In cases of brain tumor, PWI aids in grading and better differentiation in diagnostics as well as for pre-therapeutic planning. In addition, the course of treatment, both after chemo- as well as radiotherapy in combination with surgical treatment, can be optimized. PWI allows better estimates of biological activity and aggressiveness in low grade brain tumors, and in the case of WHO grade II astrocytoma showing anaplasically transformed tumor areas, allows more rapid visu-alization and a better prediction of the course of the disease than conventional MRI diagnostics. Diffusion MRI, due to the directional dependence of the diffusion, can illustrate the course and direction of the nerve fibers, as well as reconstructing the nerve tracts in the cerebrum, pons and cerebellum 3-dimensionally. Diffusion imaging can be used for describing brain tumors, for evaluating contralateral involvement and the course of the nerve fibers near the tumor. Due to its operator dependence, DTI based fiber tracking for defining risk structures is controversial. DWI can also not differentiate accurately between cystic and necrotic brain tumors, or between metastases and brain abscesses. H-MRS provides information on cell membrane metabolism, neuronal integrity and the function of neuronal structures, energy metabolism and the formation of tumors and brain tissue necroses. Diagnostic problems such as the differentiation between neoplastic and non-neoplastic lesions, grading cerebral glioma and distinguishing between primary brain tumors and metastases can be resolved. An additional contribution will discuss the control of the course of glial tumors after radiotherapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17505814     DOI: 10.1007/s00117-007-1518-4

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  16 in total

1.  [The simultaneous determination of the arterial input function for dynamic susceptibility-weighted magnetic resonance tomography of the A. carotis interna and the A. cerebri media].

Authors:  R Scholdei; F Wenz; M Essig; M Fuss; M V Knopp
Journal:  Rofo       Date:  1999-07

2.  [Preoperative imaging as the basis for image-guided neurosurgery].

Authors:  D Winkler; G Strauss; S Hesse; A Goldammer; M Hund-Georgiadis; A Richter; O Sabri; T Kahn; J Meixensberger
Journal:  Radiologe       Date:  2004-07       Impact factor: 0.635

3.  [Magnetic resonance spectroscopy. Part 2: Application in diagnosis and clinical research].

Authors:  P Bachert; M P Lichy
Journal:  Radiologe       Date:  2004-01       Impact factor: 0.635

4.  [Development of neuroradiology. From the visualization of bones to molecular imaging].

Authors:  W Reith
Journal:  Radiologe       Date:  2005-04       Impact factor: 0.635

5.  Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy.

Authors:  M Fuss; F Wenz; M Essig; M Muenter; J Debus; T S Herman; M Wannenmacher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-10-01       Impact factor: 7.038

Review 6.  MR imaging of CNS tumors: are all contrast agents created the same?

Authors:  Marco Essig
Journal:  Neuroradiology       Date:  2006-04       Impact factor: 2.804

7.  Effects of three different doses of a bolus injection of gadodiamide: assessment of regional cerebral blood volume maps in a blinded reader study.

Authors:  R Bruening; C Berchtenbreiter; N Holzknecht; M Essig; R H Wu; A Simmons; A Heuck; A Maschek; M Meusel; S C Williams; T Cox; M V Knopp; M Reiser
Journal:  AJNR Am J Neuroradiol       Date:  2000-10       Impact factor: 3.825

8.  Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.

Authors:  T Sugahara; Y Korogi; M Kochi; I Ikushima; T Hirai; T Okuda; Y Shigematsu; L Liang; Y Ge; Y Ushio; M Takahashi
Journal:  AJR Am J Roentgenol       Date:  1998-12       Impact factor: 3.959

9.  Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging.

Authors:  K A Rempp; G Brix; F Wenz; C R Becker; F Gückel; W J Lorenz
Journal:  Radiology       Date:  1994-12       Impact factor: 11.105

10.  [Noninvasive measurement of relative cerebral blood flow with the blood bolus MRI arterial spin labeling: basic physics and clinical applications].

Authors:  M-A Weber; A Kroll; M Günther; S Delorme; J Debus; F L Giesel; M Essig; H-U Kauczor; L R Schad
Journal:  Radiologe       Date:  2004-02       Impact factor: 0.635

View more
  5 in total

Review 1.  [Visualization of radiation effects on the central nervous system].

Authors:  M Essig; J Dinkel; C Zamecnik
Journal:  Radiologe       Date:  2012-03       Impact factor: 0.635

2.  Value of diffusion kurtosis imaging in assessing low-grade gliomas.

Authors:  Mohammed Z Goryawala; Deborah O Heros; Ricardo J Komotar; Sulaiman Sheriff; Efrat Saraf-Lavi; Andrew A Maudsley
Journal:  J Magn Reson Imaging       Date:  2018-03-23       Impact factor: 4.813

Review 3.  Gliomas in adults.

Authors:  Thomas Schneider; Christian Mawrin; Cordula Scherlach; Martin Skalej; Raimund Firsching
Journal:  Dtsch Arztebl Int       Date:  2010-11-12       Impact factor: 5.594

4.  [Perioperative lesions of the corticospinal tract. Etiology, neuroradiological features and clinical outcome].

Authors:  E Hattingen; A Szelényi; J Rathert; S Blasel; F Zanella; S Weidauer
Journal:  Radiologe       Date:  2009-05       Impact factor: 0.635

5.  Evaluation of high-grade astrocytoma recurrence patterns after radiotherapy in the era of temozolomide: A single institution experience.

Authors:  Arno Lotar Cordova; Taynná Vernalha Rocha Almeida; Cintia Mara da Silva; Pedro Argolo Piedade; Cristiane Maria Almeida; Carlos Genesio Bezzera Lima; Carolina Dutra; Rafael Martins Ferreira; Marcelo Neves Linhares; Valeriy Denyak
Journal:  Rep Pract Oncol Radiother       Date:  2018-03-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.